×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
Concurrent Breakout Session 2A: Optimization of R&D Programs and Portfolios
Session Chair(s)
Zoran Antonijevic, MSc
Vice President, Statistical Consulting
Abond CRO Inc., United States
Speaker(s)
Simulating the Whole Development Program to Help Optimize the Design of a Phase 2 Trial in Oncology
Tom Parke
Berry Consultants, United Kingdom
Consultant
Extension of Neuropathic Pain Development Program Optimization Via Consideration of Including 1 or 2 Doses in Phase 3
James Bolognese
Cytel Inc., United States
Senior Director of Clinical Trial Services
Maximizing Return on Investment in Designing Clinical Trials
Cong Chen, PhD
Merck & Co., Inc., United States
Director
Q&A Panel Discussion
Panel Discussion
All Session Speakers, United States
Have an account?